Schizophrenia

N Engl J Med. 2003 Oct 30;349(18):1738-49. doi: 10.1056/NEJMra035458.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use*
  • Brain / drug effects
  • Brain / physiopathology
  • Child
  • Clozapine / therapeutic use
  • Dopamine / physiology
  • Dopamine Antagonists / adverse effects
  • Dopamine Antagonists / therapeutic use
  • Dopamine D2 Receptor Antagonists
  • Humans
  • Pyramidal Cells / drug effects
  • Pyramidal Cells / physiopathology
  • Schizophrenia / drug therapy*
  • Schizophrenia / genetics
  • Schizophrenia / physiopathology

Substances

  • Antipsychotic Agents
  • Dopamine Antagonists
  • Dopamine D2 Receptor Antagonists
  • Clozapine
  • Dopamine